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The UDP-galactose (UDP-Gal) transporter present in the Golgi apparatus is a member of a transporter family comprising hydrophobic proteins
with multiple transmembrane domains. Co-immunoprecipitation experiments showed that the full-length UDP-Gal transporter protein forms
oligomeric structures in the MDCK cell. A ricin-resistant mutant of the MDCK cell line (MDCK-RCAr) is deficient in galactose linked to
macromolecules because of a lower UDP-Gal transport rate into the Golgi apparatus. We cloned this mutated protein and found that it contains a
stop codon close to the 5′ terminus of its open reading frame. We also detected a shorter splicing variant of the UDP-Gal transporter which
contains a 183-nt in-frame deletion in both the wild-type and the mutant mRNA. We showed that the protein, when overexpressed, is localized in
the Golgi apparatus and could partially correct the phenotype of the MDCK-RCAr and CHO-Lec8 mutant cell lines. The level of mRNA of the
UDP-Gal transporter is much lower (25–30 copies per cell) than those of the CMP-sialic acid transporter (100 copies per cell), UDP-N-
acetylglucosamine transporter (80 copies per cell), and GDP-fucose transporter (65 copies per cell). The transcript level of the shorter splicing
variant of the UDP-Gal transporter is extremely rare in wild-type MDCK cells (a few copies per cell), but it is significantly increased in the mutant,
RCA-resistant cells.
© 2005 Elsevier B.V. All rights reserved.Keywords: UDP-galactose transporter; MDCK; Golgi apparatus; Membrane protein1. Introduction
Nucleotide-sugar transporters (NSTs) are proteins which
provide essential components of the glycosylation pathways in
eukaryotic cells (for reviews, see [1–4]). They function to
translocate activated sugars from the cytosol into the lumen of
the endoplasmic reticulum and the Golgi apparatus. The best-
characterized proteins include the mammalian transporters for
UDP-galactose (UDP-Gal) [5,6], CMP-sialic acid (CMP-SA)
[7,8], UDP-N-acetylglucosamine (UDP-GlcNAc) [9], the yeast
transporters for UDP-GlcNAc [10] and UDP-Gal [11,12], and
the Leishmania GDP-mannose (GDP-Man) transporter [13,14].
In recent years, the genes encoding nucleotide-sugar transpor-
ters have been cloned from several species [15–23]. These
genes encode structurally related hydrophobic membrane⁎ Corresponding author. Tel.: +48 71 3752 710; fax: +48 71 3752 608.
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doi:10.1016/j.bbamcr.2005.12.006proteins. Hydropathy analysis predicted eight or nine trans-
membrane domains, but Eckhardt et al. [24] determined by an
epitope-insertion analysis that the CMP-SA transporter has ten
transmembrane domains with both the N- and C-termini facing
the cytoplasm. Several reports suggest that NSTs function as
oligomers. The formation of homodimers has been reported for
the rat Golgi UDP-GlcNAc and GDP-Fuc transporters [25,26]
and the yeast Golgi GDP-Man transporter [27,28]. There is also
evidence of a hexameric complex in the Leishmania GDP-Man
transporter [29]. Because the PAPS transporter appears to be a
homodimer in situ [30], it is possible that the leucine-zipper
motif present in this protein participates in its oligomerization.
The Kluyveromyces lactis UDP-GlcNAc [20] and murine CMP-
sialic acid [7] transporters also contain leucine-zipper motifs,
suggesting a possibility of oligomeric structure formation. The
homodimer structure may permit the formation of translocation
membrane channels, although its presence has not been
demonstrated in all NSTs.
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distinct substrate specificities. They were thought to be specific
to one substrate; however, in humans, Caenorhabditis elegans,
and Drosophila both monospecific and multispecific transpor-
ters have been cloned and characterized [17,18,31,32]. Although
some multisubstrate nucleotide-sugar transporters can be
considered orthologs, they differ in the kind and number of
UDP-activated sugars that are transported. Most of the
information concerning nucleotide-sugar transporters struc-
ture–function comes from data involving chimeras of human
UDP-Gal and CMP-SA transporters and shows that different
transmembrane domains are involved in substrate recognition
[33,34]. It has been shown that NSTs involved in the transport of
nucleotide-sugars from the cytosol into the Golgi apparatus or
endoplasmic reticulum lumen act as antiporters [35,36],
exchanging the nucleotide-sugar with the corresponding nucle-
oside monophosphate, which is a product of the glycosylation
reaction.
Several Golgi NSTs have been cloned by phenotypic
correction of the corresponding transport mutants and by in
vitro characterization of the transport activity using microsomal
fractions [5–7,11,13,20]. Yeast, Leishmania, and mammalian
cell line mutants impaired in the transport of specific nucleotide-
sugars into the Golgi lumen have severe deficiencies of the
corresponding sugar in their macromolecules [1], demonstrating
the essential role of the transport process in glycosylation
[1,10,37–39]. In addition, fibroblasts from a patient with a
clinical phenotype resembling that of leukocyte adhesion
deficiency II are defective in GDP-fucose transport into the
Golgi [40]. These mutants were isolated based on their resistance
to plant lectins.
The Madin–Darby canine kidney (MDCK) mutant cell line
(MDCK-RCAr) was isolated based on its resistance to Ricinus
communis agglutinin (RCA). The cells tolerate a 10 times higher
concentration of the lectin than do the wild-type cells [41]. Ricin
toxicity requires binding to terminal galactosyl residues, and the
ricin-resistant phenotype ofMDCK-RCAr cells correlates with a
pleiotropic deficiency in galactosylation of glycoproteins and
glycosphingolipids [37]. The MDCK-RCAr [37] and the
Chinese hamster ovary (CHO) CHO-Lec8 [42–44] mutant cell
lines have a 70–90% deficiency of galactose in their
glycoproteins, glycosphingolipids, and selective proteoglycans.
Glycoproteins and glycosphingolipids are also deficient in sialic
acid because this sugar is most often attached to galactose. The
altered phenotype of these cells was determined to have a 95–
98% deficiency in the rate of transport of UDP-Gal into the
Golgi vesicles, while the transport of other nucleotide-sugars,
including uridine derivatives and CMP-SA,was similar to that of
the wild-type cells [37,45]. The levels of activity of galactosyl-
transferases and sialyltransferases were the same in the mutant
and the wild-type cells. The defect resulted in the enrichment of
cell surface glycoconjugates bearing terminal N-acetylglucosa-
mine and of glucosylceramides, both endogenous acceptors for
galactose, while polymers with galactose in the linkage region
between the protein and the polymer, such as chondroitin and
heparan sulfate, were unaltered [38]. Keratan sulfate, which has
galactose in its polymer, was almost absent in the mutant cells.In an attempt to further characterize the UDP-Gal transporter,
we identified the mutation present in this gene in the MDCK-
RCAr mutant cell line. We found that both the wild-type and the
mutant cells, in addition to full-length UDP-Gal transporter
mRNA, contain a shorter splicing variant of this mRNA. We
determined the level of mRNA encoding both splicing variants
of the UDP-Gal transporter as well as four other nucleotide-
sugar transporters in MDCK cells. We also confirmed that the
UDP-Gal transporter, similar to other NSTs, forms oligomeric
structures in the Golgi apparatus.
2. Materials and methods
2.1. Chemicals and reagents
All chemicals were purchased from Sigma Chemical (St. Louis, MO) unless
otherwise indicated. MEM and alpha-MEM media, fetal bovine serum (FBS),
media-grade streptomycin and penicillin, PCR Platinum Supermix, Thermo-
script cDNA Synthesis Kit, and G418 were from Gibco BRL (Gaithersburg,
MD) and molecular biology grade agarose and CAPS were from ICN (Costa
Mesa, CA). Superfect transfection reagent, DNase, DNeasy, RNeasy, and
Qiagex nucleic acid isolation and purification kits were from Qiagen (Valencia,
CA), NothernMax Kit and RT-PCR Competitor Construction Kit were from
Ambion (Austin, TX), and all organic solvents were from Fisher (Pittsburgh,
PA). Nitrocelulose membranes, prestained protein standards, acrylamide/bis-
acrylamide solutions, ammonium persulfate, TEMED, non-fat milk, and Tween
20 were purchased from BioRad (Hercules, CA), anti-mouse monoclonal
antibodies against HA, c-myc and FLAG tags from Babco (Richmond, CA),
anti-mouse, and HRP-labeled secondary antibodies were from Promega
(Madison, WI), Renaissance Western blot Reagent Plus from Perkin Elmer,
pcDNA TOPO and pCR2.1 vectors, and Hygromycin B were from Invitrogen
(Carlsbad, CA), and the Complete protease inhibitor set, MAA lectin, NBT
phosphatase substrate, and Fast Ligation Kit from Roche (Indianapolis, IN).
Protein Assay Reagent was purchased were from Pierce (Rockford, IL).
2.2. Mammalian cell lines
MDCK wild-type cells, CHO wild-type cells and CHO-Lec8 mutant cells
were from ATCC (Manassas, VA), and the Riccinus communis agglutinin-
resistant strain of MDCK-RCAr cells was provided by Dr. Enrique Rodriguez-
Boulan (Department of Cell Biology and Anatomy, Cornell University Medical
College, New York).
MDCK cell lines were grown in 5% CO2 at 37 °C in MEM medium,
containing 10% fetal bovine serum (FBS) and penicillin/streptomycin. The
CHO cell lines were grown in 37 °C under 5% CO2 in alpha-MEM medium
containing 10% FBS and penicillin/streptomycin.
2.3. SDS-PAGE and immunoblotting analysis
SDS-PAGE was performed on 10% polyacrylamide gels [46]. After
electrophoresis, the proteins were transferred at 400 mA for 90 min onto
nitrocellulose membrane in 30 mM 3-cyclohexylamino-1-propane sulfonic acid
(CAPS, pH 11) containing 10%methanol. The membranes were blocked in PBS
containing 5% non-fat milk for 12 h at room temperature. The primary
antibodies were diluted 1:1000 (anti-HA, anti-c-myc, anti-FLAG) or 1:5000
(anti-V5) in PBS, containing 1% non-fat milk and 0.5% Tween 20. Secondary
HRP-conjugated antibodies were used as 1:10,000 diluted solution. The reaction
was developed using Renaissance Western Blot Reagent Plus.
2.4. Detection of terminal α2–3-linked sialic acid in cell lysates
Cell extract proteins (20 μg) were separated on 10% polyacrylamide gels
[46] and then transferred onto nitrocellulose membranes at 600 mA for 1 h in
cold CAPS buffer. The membranes were blocked in 3% BSA in TBS and then
incubated with digoxygenin-labeled MAA lectin (5 μg/ml) in TBS, washed
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conjugated with alkaline phosphatase (0.2 μg/ml) in TBS. Color reaction was
developed using NBT phosphatase substrate.
2.5. RNA purification, PCR and RT-PCR analyses
The RNeasy Mini Kit and RNeasy Blood Mini Kit were used to purify total
RNA from cell cultures of mammalian MDCK cells and dog blood (PelFreeze),
respectively. To avoid nuclear splicing variants in the preparation and genomic
DNA contamination in purified RNA, the cytosolic protocol was chosen and
RNA was treated with DNase. The quality of RNA was checked on 1%
formaldehyde agarose gel. The concentration of purified RNA was determined
spectrophotometrically at 260 nm. Random hexamers or Oligo dT18 were used
as primers for reverse transcriptase reaction. The cDNA synthesis was
performed at 55 °C for 1 h according to the manufacturer's instructions using
2 μg of total RNA as a template.
2.6. Sequencing of canine CMP-SA and UDP-Gal transporters
The cDNA library was constructed as previously described [9]. The average
insert was 2.0 kb (±0.6 kb). The library was searched with radioactive probes
specific to the murine CMP-SA transporter (the probe encompassed positions
171–454 of the ORF) and human UDP-Gal transporter (the probe encompassed
positions 608–941 of the ORF). The positive clones were collected and
fragments of the library were sequenced. One of the clones from CMP-SA
transporter screening contained the complete ORF of the canine transporter
(EMBL accession number AY064407). Five positive clones containing UDP-
Gal transporter sequences lacked the 5′ end of the ORF. Therefore, we employed
the 5′RACE Kit (Gibco) to identify the full-length ORF of the transporter
(EMBL accession number AY064406).
2.7. Construction of mammalian expression plasmids
The ORF of UDP-Gal transporter was amplified from cDNA synthesized as
described above. The forward primer (MO1, see Table 1) contained a Kozak
sequence at the 5′ end, and the reverse primer lacked the stop codon (MO2). The
PCR product was cloned into a pcDNA3.1 TOPO vector encoding the V5
epitope and 6His tag at the C-terminus of the resulting recombinant protein. To
obtain the protein with an HA tag at the C-terminus, the PCR product was
amplified using the same forward primer and reverse primer containing the
nucleotide sequence of the epitope sequence and stop codon at the 3′ end and
then cloned into the pcDNA3.1 TOPO vector. To clone the transporter with c-
myc and FLAG epitopes, the forward primer contained a HindIII restriction site
at the 5′ end and the reverse primer contained an XbaI restriction site at the 5′
end. The PCR product was cloned into a pCDNA3.1 Hygro vector containing
the HindIII and XbaI sites in a polylinker region. All plasmids used in this study
are listed in Table 2.
2.8. Transfection of mammalian cells
To transfect CHO and MDCK cells, SuperFect lipid-mediated reagent
(Qiagen) was used. The transfection was done in 6-well plates for 3 h. After
transfection, the cells were incubated in medium without a selecting antibiotic
for 48 h and then trypsinized, diluted 1:50 and transferred to new plates
containing 500 μg/ml of G418 and/or 200 μg/ml of Hygromycin B. After several
days of selection, twelve colonies were chosen and transferred to new plates. The
lysates from one set of plates were analyzed for the presence of tagged proteins.
To obtain double transfectants for immunoprecipitation experiments, the stable
transfectants with HA-tagged UDP-Gal transporter and G418 resistance were
transfected with the same type of construct (pCDNA3.1 plasmid) but containing
a Hygromycin-resistance gene and c-myc or FLAG epitopes.
2.9. Ricin resistance of MDCK cells
The MDCK cells were trypsinized and transferred to 24-well plates (about
104 cells per well). Increasing amounts of ricin resuspended in PBS were added
to each well. The cells were grown for one week at standard conditions, thenwashed once with PBS, fixed and stained for 30 min in 50% methanol,
containing 1 mg/ml methylene blue.
2.10. Immunoprecipitation of UDP-Gal transporter overexpressed in
CHO-Lec8 mutant cells
Confluent double-transfected CHO-Lec8 cells cultured in 100-mm plates
were placed on ice, washed once with cold PBS, and then scraped in 1 ml of
RIPA buffer (50 mM Tris/HCl, pH 8.0, 0.15 M NaCl, 1% Nonidet NP-40, 0.5%
sodium deoxycholate, 0.1% SDS and Complete protease inhibitor cocktail).
After 20 min of incubation on ice, the lysates were transferred to microcentrifuge
tubes and centrifuged for 20 min at 20,000 × g at 2 °C. Supernatants were
precleared with protein G-Sepharose beads (60 μl, 30% solution in RIPA
buffer). After centrifugation, the supernatants were placed in new tubes and
incubated with 5 μl of monoclonal anti-HA antibodies. The mixture was rotated
for 2 h at 4 °C, followed by addition of 60 μl of Protein G-Sepharose beads.
After 1 h of rotation, the beads were spun down for 2 min at 20,000 × g and the
supernatants were discarded. The beads were washed 3 times with 1 ml of ice-
cold RIPA buffer, resuspended in 50 μl of 2×Laemmli sample buffer and
incubated at 60 °C for 15 min. Twenty-μl samples were loaded onto 10% SDS
polyacrylamide gel.
2.11. Estimation of mRNA levels of various nucleotide-sugar
transporters in the MDCK cell line
In order to determine the transcript level of four nucleotide-sugar
transporters, competitive RNA templates were designed. First, DNA templates
of about 300 bp in length but with a deletion of 10% compared with the original
sequences were synthesized by PCR. The forward primer contained the T7
promoter sequence (Table 1). These templates were used to produce RNA in
vitro. Because the sequence of GDP-Fuc transporter from canine cells (MDCK)
was not known, before starting the experiment we performed PCR using primers
designed for the conservative sites of the human GDP-Fuc transporter (EMBL
accession number AF323970). The discrete product was sequenced (EMBL
accession number AY064408). The fragment encompassing 119 amino acids of
the putative canine GDP-Fuc transporter showed 94% identity compared with
the human GDP-Fuc transporter (amino acid positions 63–182). Based on this
sequence, primers for the GDP-Fuc competitive assay were designed.
The RNA synthesis reaction was done using a RT-PCR Competitor
Construction Kit according to the manufacturer's instructions (Ambion). To
detect the full-length RNA competitor product and to determine the amount of
synthesized RNA, 0.4 μl of [α-32P]-GTP [800 Ci/mM] was added to the reaction
mixture. The competitive RNA was separated on 5% polyacrylamide/urea gel.
After autoradiography, gel slices containing full-length products were cut out
and RNA was eluted from the gel. The RNA was purified by precipitation in
70% ethanol and then resuspended in water. The competitor RNAwas stored in
siliconized microtubes at −70 °C.
The competitive reactions were performed according to the Ambion manual.
Briefly, cDNA from known amounts of RNA competitors were synthesized.
Different volumes from this reaction were mixed with cDNA obtained from a
constant amount (1 μg) of total RNA fromMDCK cells. The mixtures were used
as a template in PCR reactions and the intensity of two products (the full-length
original sequence and the shorter competitor sequence) were analyzed. To obtain
bands of the same intensity, a second round of PCR reactions was performed. In
the final experiment we used the original RNA competitors mixed with total
RNA from MDCK cells. These mixtures were used as templates in RT-PCR
reactions. The tubes containing equal amounts of amplified products from
original and competitor RNA were chosen to calculate the transcript level in
MDCK cells.
2.12. Northern blotting of UDP-Gal transporter
Total RNAwas purified from MDCK cells using a Qiagen RNeasy Mini Kit
and cytosolic RNA protocol according to the manufacturer's instructions. RNA
was separated on 1% formaldehyde agarose gel and transferred onto nylon
membranes. As a probe, the antisense RNA (183 bp) fragment was used. The
probe was synthesized using the transcription reaction with the appropriate DNA
Table 1
Primers used in this study
Primer Sequences of forward (F) and reverse (R) primers Description
MO1 CACATGGCAGCGGTGGGGTCCGGC (F) Amplify the ORF of
UDP-Gal transporterMO2 CTTCACCAGCACTGACTTCGGCAG (R)
MO1 CACATGGCAGCGGTGGGGTCCGGC (F) Amplify the ORF of
UDP-Gal transporter
with HA tag
MO3 TCAGAGTGATGCGTAGTCTGGTACGTCGTATGGGTACTTCACCAGCACTGACTTCGGCAG (R)
MO4 GCGAAGCTTCACATGGCAGCGGTGGGGTCCGGC (F) Amplify the ORF of
UDP-Gal transporter
with FLAG tag
MO5 GCTCTAGACGTCACTTATCGTCATCGTCCTTGTAGTCCTTCACCAGCACTGACTTCGGCAG (R)
MO4 GCGAAGCTTCACATGGCAGCGGTGGGGTCCGGC (F) Amplify the ORF of
UDP-Gal transporter
with c-myc tag
MO6 GCTCTAGACGTCAAAGATCCTCCTCGGAGATAAGCTTCTGTTCCTTCACCAGCACTGACTTCGGCAG (R)
MO7 GCTCACCGGCGCCTCAAATAC (F) Amplify the template
for antisense RNA
probe specifc to the
full-length
UDP-Gal transporter
used in Northern
Blotting
MO8 TAATACGACTCACTATAGGCCTCTTTTGTGCGAAGAGCAG (R)
Fuc-Hum-
F
CTGGTGGTCTCCCTCTACTGG (F) Amplify the fragment
of canine GDP-Fuc
transporterFuc-Hum-
R
CTGGTCCACACCAAGCCAGAA (R)
T7-Short GCGTAATACGACTCACTATAGGGAGAGGAGGGAACCGCTAGTGCGGGTAACCTGGTGCAGTATGTGGACAC (F) Primers used in
competitive
experiments to
estimate the
transcript level
of the short, splicing
variant of UDP-Gal
transporter in
MDCK cells
P1-Short GGAACCGCTAGTGCGGGTAAC (F)
P2-Short GACAGACACGAGGCCACGAC (R)
P4-Short AGGTTGCGGAGCCACACCGA (R)
T7-Gal GCGTAATACGACTCACTATAGGGAGAGGAGATGGCAGCGGTGGGGTCCGGGTCTCCGCGGGGTCGTTGGAG (F) Primers used in
competitive
experiments to
estimate the
transcript level
of the full-length
UDP-Gal
transporter in
MDCK cells
P1-Gal ATGGCAGCGGTGGGGTCCGG (F)
P2-Gal GTCCACATACTGCACCAGGAC (R)
P4-Gal CCTCTTTTGTGCGAAGAGCAGC (R)
T7-Glc GCGTAATACGACTCACTATAGGGAGAGGAGATGTCTACCAACCTAAAATACCCAGTTTGGTTCTAACAATGCG (F) Primers used in
competitive
experiments to
estimate the
transcript level
of UDP-GlcNAc
transporter in
MDCK cells
P1-Glc ATGTCTACCAACCTAAAATACC (F)
P2-Glc CTGAAGAGTATATATCCCTGATG (R)
P4-Glc GATATGTAACCTGATACGTAG (R)
T7-SA GCGTAATACGACTCACTATAGGGAGAGGAGATGGCTGCCCCAAGAGAAAATGTCCTGGTGGCTGCAGCTTATACC
(F)
Primers used in
competitive
experiments to
estimate the
transcript level
of CMP-SA
transporter in
MDCK cells
P1-SA ATGGCTGCCCCAAGAGAAAATGTC (F)
P2-SA GATGGTACACTTAACTTCATCAG (R)
P4-SA TACTGCTGCATCCAGATTGCTA (R)
T7-Fuc GCGTAATACGACTCACTATAGGGAGAGGAGAAGAGCCTCAGCACACTGGCCTTTCCCACCCTGCGCCTGGAC (F) Primers used in
competitive
experiments to
estimate the
transcript level
of GDP-Fuc
transporter in
MDCK cells
P1-Fuc AAGAGCCTCAGCACACTGGC (F)
P2-Fuc CTGCTTGAGCAGCAGGTAGC (R)
P4-Fuc AGAAGCCACCAATGATGATGC (R)
85M. Olczak, E. Guillen / Biochimica et Biophysica Acta 1763 (2006) 82–92
Table 2
Plasmids used in this study
Plasmid Description Source
pCR2.1 TOPO E. coli plasmid used for sequencing of DNA inserts Invitrogen
pcDNA3.1 TOPO Mammalian expression plasmid containing G418-resistance gene Invitrogen
pcDNA3.1 Hygro Mammalian expression plasmid containing hygromycin-resistance gene Invitrogen
pMAR1 pcDNA3.1 TOPO containing the ORF of UDP-Gal transporter with V5 and 6His epitopes This study
pMAR2 pcDNA3.1 Hygro containing the ORF of UDP-Gal transporter with HA tag This study
pMAR3 pcDNA3.1 TOPO containing the ORF of UDP-Gal transporter with FLAG tag This study
pMAR4 pcDNA3.1 TOPO containing the ORF of UDP-Gal transporter with c-myc tag This study
pMAR5 pcDNA3.1 Hygro containing the ORF of the short, splicing variant of UDP-Gal transporter with HA tag This study
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sequence from the canine UDP-Gal transporter (Table 1). The probe was labeled
with radioactive CTP. The procedure was performed according to Ambion's
NorthernMax Kit manual.
2.13. Immunofluorescence microscopy
CHO-Lec8 cells stably transfected with tagged UDP-Gal transporter
sequence or a splicing variant of the transporter, were grown to confluence on
glass 8-chamber glass slides (Fisher). The cells were washed twice with PBS,
fixed for 2 min in a methanol/acetone solution (1:1 v/v), washed again with PBS,
and permeabilized for 15 min in PBS containing 1% Triton X-100. The fixed
cells were incubated overnight with primary anti-HA monoclonal antibodies
(1:200) and anti-GOS28 rabbit serum (1:200) in permeabilization buffer at 4 °C.
After washing, the cells were stained in permeabilization buffer containing a
mixture of secondary anti-mouse goat antibodies labeled with Texas Red marker
(Molecular Probes, Eugene, OR) and anti-rabbit goat antibodies labeled with
Oregon Green (Molecular Probes). The slides were secured in mounting media
(BioRad) and analyzed using a Nikon fluorescence microscope.
2.14. Protein assay
The protein concentration in the cell lysates was determined by the
bicinchoninic acid method (BCA) [47].3. Results
3.1. Sequence of canine UDP-Gal transporter: identification of
the mutation, evidence for a full-length transporter and its
shorter splicing variant
The primary defect observed in MDCK-RCAr cells is
impaired transport of UDP-Gal into the Golgi apparatus. To
understand the nature of this mutation in the UDP-Gal
transporter, Northern blotting analysis using a highly specific
antisense RNA probe was performed in the MDCK wild-type
and mutant cell lines. The size of mRNA of the transporter in
both the wild-type and the mutant cells was about 2450 nt in
length (Fig. 1). Sequencing of cDNA from the wild-type and
the mutant cells showed that the ORF of the wild-type
transporter was 1203 bp long, similar in length to that of the
human and murine transporters. The mutant cells contained
full-length mRNAwith a point mutation at position 136, which
changes a CAG codon (Gln) to a TAG stop codon. Sequencing
of the mutated region in the genomic DNA showed that only
one of the two alleles has this stop codon. The cDNA from
these cells contained only the mutated mRNA. PCR
amplification of the UDP-Gal transporter ORF from thewild-type and the mutant cells showed an additional, shorter
product (Fig. 1). Interestingly, although the product has a 183-
bp deletion in the 5′region from position 91 to 273, the ORF
was in frame (EMBL accession number AM110117). To
confirm that both products are alternatively spliced we
sequenced the 5′ end of the genomic DNA (Fig. 1D)
(EMBL accession number AM087559). The mRNA of the
shorter splicing variant does not contain exactly exon 2.
Because the point mutation of the full-length ORF of the UDP-
Gal transporter is localized in this region (position 136), the
shorter version of the mRNA of the transporter has the same
sequence in the wild-type MDCK and mutant MDCK RCAr
cells. In an important study, we found that the shorter splicing
variant of the UDP-Gal transporter mRNA can also be
detected in leukocytes of canine blood. The sequences of the
shorter variant of the transporter isolated from the blood cells
and from the MDCK cell line were identical (data not shown),
confirming that this is not a specific feature only for MDCK
cells. The hydrophobicity plot [48] of both transporters
supported their highly hydrophobic properties and detected
that in the shorter splicing variant the first two transmembrane
domains were not present (data not shown).
3.2. mRNA levels of nucleotide-sugar transporters in the
wild-type MDCK and MDCK RCAr mutant cells
To gain information concerning the abundance of nucleotide-
sugar transcripts in the cell, competitive RT-PCR was
employed. Primers designed for unique regions were synthe-
sized to produce DNA templates specific to UDP-GlcNAc,
CMP-SA, GDP-Fuc, and UDP-Gal transporters as well as the
shorter splicing variant of the GDP-Gal transporter. The
incorporation of radioactivity was high (3–5%) and the
concentration of the purified product was about 5×1011 copies
per μl. The concentration of the competitors did not decrease
when stored in siliconized tubes at −70 °C for several weeks. As
shown in Fig. 2, the transcript levels of the CMP-SA, UDP-
GlcNAc, and GDP-Fuc transporters were similar (70–100
copies per cell), but the transcript level of the UDP-Gal
transporter seemed to be much lower (20–30 copies per cell).
Although the transcript level of the shorter splicing variant of
the UDP-Gal transporter was very low in the wild-type cell line
(a few copies per cell), we observed a significant increase in this
product in RCAr mutant cells. We also detected a decrease in the
full-length transporter mRNA (which is not functional as it has a
Fig. 1. Identification of UDP-Gal transporter in MDCK cells. (A) RT-PCR of UDP-Gal transporter from the wild-type MDCK and mutant MDCK-RCAr cells. The
arrows indicate two major products amplified. Std, molecular weight marker; lane 1, MDCK wild-type RNA; lane 2, MDCK-RCAr RNA. (B) Agarose electrophoresis
of total RNA isolated from the wild-type (lane 1) and RCA-resistant (lane 2) MDCK cells. Two μg of total RNAwas loaded on each lane. (C) Northern blotting. The
183-nt 32P-labeled antisense RNA probe specific to the full-length UDP-Gal transporter only. Lane 1, MDCK wild-type RNA; lane 2, MDCK-RCAr RNA; lane 3,
molecular weight marker. The 414-nt antisense RNA probe derived from a sequence of canine β-actin was used as a control. (D) Schematic representation of the 5′ end
of genomic DNA encoding the UDP-Gal transporter in MDCK cells.
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mutant cells, which confirmed the Northern blotting results.
3.3. The full-length of the UDP-Gal transporter and its shorter,
splicing variant correct the mutant phenotype of MDCK-RCAr
and CHO-Lec8 cells
To demonstrate that the mutation detected in the UDP-
Gal transporter mRNA was indeed responsible for the RCAr
phenotype, the full-length PCR product of the transporter
was overexpressed in these mutant cells (Fig. 3). Phenotypic
correction was measured by detecting terminal α2–3-linked
sialic acid with MAA lectin, since glycoproteins with lower
levels of galactosylation are supposed to be less sialylated.
As expected, the wild-type UDP-Gal transporter corrected
the phenotype of RCAr cells (Fig. 3). In addition, we found
that a low overexpression level caused more efficient
recovery of the wild-type phenotype compared with clones
expressing higher level of the recombinant protein. It is
likely that higher expression levels might be toxic to MDCK
cells.
The effect of overexpression of the shorter splicing variant of
the UDP-Gal transporter was also examined using the lectin-
resistance test (Table 3). MDCK RCAr cells were grown to
confluence in the presence of 2.7 ng/ml of ricin, which is about
30 times higher than that used for the wild-type cells. Mutantcells corrected by overexpression of the wild-type UDP-Gal
transporter were sensitive to ricin in a manner similar to that of
the wild-type cells. We also observed partial correction of the
sensitivity to ricin when the shorter splicing variant of UDP-Gal
transporter was overexpressed. The cells were resistant to up 0.4
ng/ml of ricin present in the medium. This suggested that higher
amounts of this splicing variant could partially compensate the
lack of a full-length transporter.
The CHO-Lec8 mutant cell line does not produce UDP-Gal
transporter mRNA [49]. Therefore we used these cells to
overexpress the canine UDP-Gal transporter. Fig. 4 shows
overexpression of this transporter and its shorter splicing variant
in CHO-Lec8 cells. Although the level of the shorter protein
was lower compared with the full-length UDP-Gal transporter,
both transcripts were stable in CHO cells. Fig. 4 shows the
levels of terminal α2–3-linked sialic acid in CHO-Lec8
glycoproteins after overexpression of both splicing variants.
The full-length canine transporter could correct the defect, but
the shorter version of the transcript (the splicing variant) of the
transporter from MDCK cells also caused a slight increase in
sialylation.
3.4. Localization of canine UDP-Gal transporter
CHO-Lec8 mutant cells were also used to overexpress
the canine full-length UDP-Gal transporter and its shorter
Fig. 2. mRNA levels of the Golgi transporters in MDCK cells. The final
calculations were done based on RNA competitor experiments. Constant
amounts of total RNA isolated from MDCK cells were mixed with known
amounts of competitive RNA. The error bars indicate standard deviation (SD)
from four independent experiments.
Fig. 3. Correction of the MDCK-RCAr mutant phenotype. (A) Overexpression
of canine UDP-Gal transporter and its shorter splicing variant in MDCK-RCAr
mutant cells. Proteins (30 μg) were separated on 10% SDS-PAGE and after
transfer probed with anti-V5 antibodies and anti-mouse antibodies conjugated
with horseradish peroxidase. Lane 1, MDCK-RCAr cells overexpressing the
full-length UDP-Gal transporter with the C-terminal V5/6His fusion peptide;
lane 2, MDCK-RCAr cells overexpressing the shorter splicing variant of the
UDP-Gal transporter with the C-terminal V5/6His fusion peptide. (B) Silver
staining of proteins (20 μg per lane) in cell lysates. (C) Western blotting of cell
lysates after staining with MAA lectin, specific to terminal α2–3-linked sialic
acid. Lane 1, wild-type MDCK cells; lane 2, MDCK-RCAr cells; lane 3,
MDCK-RCAr cells overexpressing the full-length MDCK UDP-Gal transporter
(clone WH3); lane 4, MDCK-RCAr mutant cells overexpressing the full-length
MDCK UDP-Gal transporter (clone WH4). Clone WH4 overexpressed more
protein than clone WH3 (data not shown).
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fluorescence microscopy. The MDCK cells were very
sensitive to the expression of the tagged shorter splicing
variant probably because of the high toxic effect of the
protein produced at high concentration (the endogenous
protein is also present in RCAr mutant cells). Fig. 5 shows
that both proteins are located in the cells with the GOS28
Golgi apparatus protein marker.
3.5. UDP-Gal transporter forms oligomers in the Golgi
apparatus
To examine the putative oligomeric structure of the UDP-
Gal transporter, we employed co-immunoprecipitation experi-
ments performed in CHO-Lec8 mutant cells. The cells were
stably transfected with pcDNA3.1 plasmid containing the
ORF of the canine UDP-Gal transporter with the HA tagsequence at the C-terminus and the G418-resistance gene.
After detection of the expression of the tagged protein, one
clone was chosen and transfected with the same type of
plasmid containing the same ORF but with FLAG or c-myc
at the C-terminal region and the hygromycin-resistance gene.
Twelve clones were chosen to determine the expression
levels of the tagged transporters in the cells (Fig. 6). Fig. 7
shows Western blotting of lysates containing HA/c-myc and
HA/FLAG-tagged proteins immunoprecipitated with anti-HA
monoclonal antibodies and detected on the membrane with
anti-c-myc antibodies. Our results showed that UDP-Gal
transporter forms oligomeric structures in the cell. We were
Table 3
Ricin-resistance of the wild type MDCK, mutant MDCK-RCAr and MDCK-
RCAr mutant cells overexpressing two splicing variants of canine UDP-Gal
transporter
MDCK cell line Minimal lethal concentration
of ricin in the medium (ng/ml)
Wild type 0.19
RCAr with empty vector pDNA3.1 2.80
RCAr with full-length splicing variant 0.10
RCAr with short splicing variant 0.66
Fig. 4. Correction of the CHO-Lec8 mutant phenotype. (A) Overexpression of
canine UDP-Gal transporter and its shorter splicing variant in CHO-Lec8 mutant
cells. Proteins (60 μg) were separated on 10% SDS-PAGE and after transfer
probed with anti-V5 antibodies and anti-mouse antibodies conjugated with
horseradish peroxidase. Lane 1, CHO-Lec8 cells overexpressing the full-length
UDP-Gal transporter with the C-terminal V5/6His fusion peptide; lane 2, CHO-
Lec8 cells overexpressing the shorter splicing variant of the UDP-Gal
transporter with the C-terminal V5/6His fusion peptide. (B) Silver staining of
proteins (20 μg per lane) in cell lysates. (C) Western blotting of cell lysates after
staining with MAA lectin, specific to terminal α2–3-linked sialic acid. Lane 1,
wild-type CHO cells; lane 2, CHO-Lec8 cells; lane 3, CHO-Lec8 cells
overexpressing the full-length MDCK UDP-Gal transporter (clone H1); lane 4,
CHO-Lec8 mutant cells overexpressing the full-length MDCK UDP-Gal
transporter (clone H3); lane 5, CHO-Lec8 mutant cells overexpressing the
shorter splicing variant of the UDP-Gal transporter fromMDCK cells. Clone H1
overexpressed more protein than clone H3 (data not shown).
89M. Olczak, E. Guillen / Biochimica et Biophysica Acta 1763 (2006) 82–92not able to prove this using anti-FLAG antibodies in Western
blotting of HA-immunoprecipitated UDP-Gal transporter
(data not shown). We showed that the protein has lower
molecular weight when overexpressed with FLAG tag (about
35 kDa). In contrast, c-myc-tagged protein as well as V5–
6His-tagged protein both showed the predicted molecular
weight of 46 kDa. It is likely that the FLAG-tagged protein
is truncated and may not form stable oligomers in vivo.
4. Discussion
To gain more information regarding various NSTs, first
we identified the sequence encoding the entire UDP-Gal
transporter from the MDCK cell line. The predicted protein
is highly homologous to other UDP-Gal transporters present
in the mouse [2,3] and hamster [49]. In these cells only one
form of the transporter was found. In contrast, two UDP-Gal
isoforms (UGT1 and UGT2), resulting from alternative
splicing, were detected in humans [5,6]. The UDP-Gal
transporter identified in MDCK cells is homologous to the
human UGT1 splicing variant. We showed that it localized
to the Golgi-like structures. Recently, other investigators
reported on different locations of the two human UGT
isoforms [49,50]. They found that the UGT1 form was
localized in the Golgi apparatus, whereas the UGT2 form
was present in both the Golgi apparatus and the endoplasmic
reticulum. The dilysine motif in the C-terminal region of the
transporter seems to be responsible for these differences [50].
In agreement with these studies, UDP-Gal from MDCK
cells, which does not possess this motif, was also found in
the Golgi apparatus. However, we cannot rule out the
possibility that in these cells a UGT2-like variant is also
present.
Further, we identified the entire sequence of the CMP-SA
transporter and the fragment of the GDP-Fuc transporter and
determined the transcript levels encoding four major Golgi
NSTs. We found that the levels of mRNA of all the transporters
analyzed in the MDCK cell are quite low. The UDP-Gal
transporter mRNA level is much lower than the mRNAs
encoding other transporters. RNA encoding the CMP-SA
transporter is the most abundant, whereas the levels of UDP-
GlcNAc and GDP-Fuc transporters transcripts are lower.
The MDCK-RCAr [37] and the CHO-Lec8 [42–44]
mutant cell lines belong to the same genetic complementation
group. The altered phenotype of these cells is caused by an
impaired rate of UDP-Gal transport into the Golgi vesicles.To date, molecular defects in several CHO-Lec8 isolates have
been very well characterized [49]. Out of nine independent
clones, six expressed truncated UDP-Gal transporter tran-
scripts, whereas three mutants possessed the transporter with
a single amino acid replacement. Although the RCA-resistant
mutant of the MDCK cell line has been very well known to
be deficient in galactose attached to macromolecules, the
nature of this mutation has not yet been identified. In this
study we characterized a mutation in the gene encoding
canine UDP-Gal transporter protein. We detected this defect
as a point mutation at position 136 of the ORF, which
replaces the Gln codon with a stop codon. Although the
mutation is present in one allele only (the second allele has a
wild-type genotype), the MDCK-RCAr mutant cell line
produces the non-functional, mutated mRNA. Therefore it is
not clear why cells lacking the UDP-Gal transporter are still
Fig. 5. Localization of the shorter splicing variant of the UDP-Gal transporter (A) and the full-length UDP-Gal transporter (B). CHO-Lec8 mutant cells were grown on
chamber glass slides in standard conditions. Anti-HA monoclonal antibodies were used to detect transfectant proteins. Secondary anti-mouse antibodies were
conjugated with Texas Red dye. Polyclonal antibodies raised against Golgi protein GOS28 were used as the Golgi apparatus marker. Secondary anti-rabbit antibodies
were conjugated with Oregon Green dye. Both overexpressed products, UDP-Gal full-length transporter (panel B) and its shorter splicing variant (panel A), are
localized in the Golgi-like structures.
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[37]. This effect may be explained, at least in part, by the
presence of another transporter for UDP-Gal localized in the
Golgi apparatus or transporters specific to other nucleotide-
sugars, which can also transfer UDP-Gal at lower rates.
Oelmann et al. [49] found a similar mutation in CHO-Lec8
cells caused by a deletion of 100 bp in the coding region of
the UDP-Gal transporter, introducing a premature stop codon.Fig. 6. Western blotting of 12 clones of CHO-Lec8 cells stably transfected with UDP-
the picture; panels A and C) and 12 clones of CHO-Lec8 cells stably transfected with U
side of the picture; panels C and D). Clone #11 of the HA/c-myc double transfectan
immunoprecipitation experiment. Panel A, staining with anti-c-myc antibodies; pane
antibodies.This truncated protein (about 10 kDa) was stable but localized
to the endoplasmic reticulum. Although we did not over-
express and did not examine the localization of the truncated
(about 4.5 kDa) protein which could be produced by the
MDCK-RCAr mutant cells, we suspect that such a short
protein would be not functional.
In this study, we also detected a second splicing variant
of the UDP-Gal transporter in MDCK cells. The predictedGal transporter with HA tag and UDP-Gal transporter with c-myc tag (left side of
DP-Gal transporter with FLAG tag and UDP-Gal transporter with HA tag (right
ts and clone #1 of the FLAG/HA double transfectants were chosen for the co-
l B, staining with anti-FLAG antibodies; panel C and D, staining with anti-HA
Fig. 7. Co-immunoprecipitation of canine UDP-Gal transporter. The lysates
from CHO-Lec8 cells transfected with both c-myc-tagged and HA-tagged UDP-
Gal transporter fusion proteins (clone #1, Fig. 6A and C) were immunopreci-
pitated with anti-HA antibodies and then bound to Protein G-Sepharose beads.
Proteins were separated by SDS-PAGE and after transfer probed with anti-c-myc
monoclonal antibodies. The HA/FLAG double transfectant lysate (clone #1, Fig.
6B and D), treated as described above, was used as a negative control. Lane 1,
control sample; lane 2, immunoprecipitated sample.
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than the full-length transporter. Compared with the levels of
the transcripts encoding other transporters examined in this
study, mRNA encoding the shorter splicing variant version
is extremely rare. The sequences of shorter splicing variant
of the UDP-Gal transporter from wild-type MDCK and
mutant RCAr cells are identical, but their mRNA levels are
higher in the mutant cells. This may be a kind of
compensatory effect in the cells which probably do not
produce the functional protein. The shorter splicing variant
of the UDP-Gal transporter could partially correct the
galactosylation defect in the mutant CHO-Lec8 cells. We
also observed partial phenotype correction of MDCK-RCAr
cells after overexpression of this splicing variant. It might be
possible that the presence of this splicing variant in RCA-
resistant cells could explain the fact that some proteins and
proteoglycans still contain galactose. We also showed that
the shorter splicing variant of the UDP-Gal transporter
detected in the MDCK cell line is also present in canine
leukocytes, suggesting that its occurrence is not only limited
to the MDCK cell line.
Several investigators demonstrated that NSTs function as
dimers or higher order oligomers [25–29]. However, no
report showing oligomers of UDP-Gal transporter have been
published. Using co-immunoprecipitation experiments we
confirmed that UDP-Gal transporter forms oligomeric
structures. Compared with ultracentrifugation, a method
used previously by other investigators [25–27,29], thedetection of oligomers using co-immunoprecipitation sug-
gests that protein monomers interact with high affinity. We
also observed that overexpressed UDP-Gal transporter
protein tagged with FLAG epitope migrates differentially
in SDS-PAGE compared with the protein with V5–6His,
HA or c-myc epitopes. This may suggest different
susceptibility to proteolysis of these proteins, but also
posttranslational modification of the transporter depending
on the C-terminal fusion protein attached. Since the kind of
the fusion protein attached to the recombinant protein may
influence its functionality, it should be taken into consider-
ation that various transporters with different tags should be
examined.
In conclusion, in this study we reported on canine UDP-
Gal transporter sequence identification and characterization
of the mutation responsible for defective UDP-galactose
transport in MDCK-RCAr cells. In addition, the copy
number per MDCK cell of UDP-Gal transporter in
comparison with other NSTs was presented. We also
identified the shorter splicing variant of the UDP-Gal
transporter present in canine cells. Further studies will
focus on detailed analysis of the glycoproteins produced in
MDCK-RCAr mutant cells as well as on the characterization
of the putative proteins involved together with the UDP-Gal
transporter in UDP-galactose transport into the Golgi
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